Use of the bolus tracking technique for the tomographic evaluation of the uretero-vesicular junction in dogs and assessment of dose records

Table 1 Breed, Weight, Age, Sex, CT indication and Anaesthetic Protocols

Breed	Weight (kg)	Age (years)	Sex	CT indication	Anaesthetic protocol
Akita	30	13	NF	rectal neoplasm	I: dex 3 μg/kg e.v. + ppf ∼ 2,5 mg/kg e.v.
Akita	30	13	NF	rectal neoplasm	M: iso in oxygen 100 %
Pinscher	6	14	IM	bone neoplasm	I: dex 3 μg/kg e.v. + ppf ∼ 2,5 mg/kg e.v
Pinscher	6	14	IM	bone neoplasm	M: iso in oxygen 100 %
Mixed breed	5,5	8	IM	suspected hepatic neoplasm	I: dex 3 μg/kg e.v. + ppf ∼ 2,5 mg/kg e.v.
Mixed breed	5,5	8	IM	suspected hepatic neoplasm	M: iso in oxygen 100 %
Irish Setter	26	8	NF	mammary neoplasm	I: dex 3 μg/kg e.v. + ppf ∼ 2,5 mg/kg e.v
Irish Setter	26	8	NF	mammary neoplasm	M: iso in oxygen 100 %
Labrador Retriever	32	10	NF	hepatic/splenic neoplasm	P: dex 1 μg/kg e.v + but 0,2 mg/kg e.v.
					I: ppf e.v. to effect (∼ 4 mg/kg)
					M: iso in oxygen 100 %
Pinscher	5	8	IF	mammary neoplasm	P: dex 5 μg/kg i.m. + met 0,2 mg/kg i.m.
					I: ppf ∼ 2,5 mg/kg e.v
					M: iso in oxygen 100 %
Mixed breed	30	11	IF	mammary neoplasm	P: dex 5 μg/kg i.m. + met 0,2 mg/kg i.m.
					I: ppf e.v. to effect (∼ 4 mg/kg)
					M: iso in oxygen 100 %
Pinscher	2,8	8	IF	mammary neoplasm	P: dex 10 μg/kg i.m. + but 0,2 mg/kg i.m.
					I: ppf e.v. to effect (∼ 4 mg/kg)
					M: iso in oxygen 100 %
Pug	11	12	IM	mandibular neoplasm	P: but 0,2 mg/kg e.v.
					I: ppf e.v. to effect (∼ 4 mg/kg)
					M: iso in oxygen 100 %
English Setter	20	10	IF	mammary neoplasm	P: dex 5 μg/kg i.m. + met 0,2 mg/kg i.m.
					I: ppf e.v. to effect (∼ 4 mg/kg)
					M: iso in oxygen 100 %

NF neutered female, IM intact male, IF intact female, P premedication, I induction, M maintenance, ppf propofol, dex dexmedetomidine, iso isoflurane, but butorphanol, met methadone

ISSN: 1746-6148